Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.4900
-0.0250 (-4.85%)
At close: Jun 18, 2026
Aspira Women's Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.34 | 1.76 | 1.77 | 2.6 | 13.31 | 37.18 |
Cash & Short-Term Investments | 1.34 | 1.76 | 1.77 | 2.6 | 13.31 | 37.18 |
Cash Growth | -59.42% | -0.79% | -31.88% | -80.48% | -64.21% | 123.56% |
Receivables | 1.42 | 1.21 | 0.99 | 1.46 | 1.25 | 1.03 |
Inventory | 0.29 | 0.26 | 0.33 | 0.23 | 0.32 | 0.17 |
Prepaid Expenses | 0.73 | 0.85 | 1.1 | 1 | 1.44 | 1.62 |
Total Current Assets | 3.79 | 4.06 | 4.18 | 5.28 | 16.31 | 40.01 |
Property, Plant & Equipment | 0.97 | 1.03 | 1.26 | 0.69 | 0.65 | 0.81 |
Other Intangible Assets | 0.28 | 0.31 | - | - | - | - |
Other Long-Term Assets | 0.06 | 0.06 | 0.05 | 0.29 | 0.41 | 0.26 |
Total Assets | 5.09 | 5.46 | 5.49 | 6.26 | 17.37 | 41.08 |
Accounts Payable | 1.97 | 1.24 | 2.17 | 1.26 | 0.88 | 1.5 |
Accrued Expenses | 1.3 | 1.3 | 2.45 | 2.86 | 3.4 | 5.3 |
Short-Term Debt | 1.87 | 0.49 | 0.61 | 0.67 | 0.76 | 0.78 |
Current Portion of Long-Term Debt | 0.24 | 0.24 | 0.23 | 0.17 | 0.4 | 0.2 |
Current Portion of Leases | 0.21 | 0.2 | 0.01 | 0.16 | 0.08 | 0.06 |
Total Current Liabilities | 5.6 | 3.47 | 5.47 | 5.12 | 5.53 | 7.84 |
Long-Term Debt | 0.98 | 1.04 | 1.28 | 1.43 | 2.32 | 2.72 |
Long-Term Leases | 0.96 | 1.01 | 1.25 | 0.43 | 0.27 | 0.35 |
Other Long-Term Liabilities | 3.76 | 6.87 | 0.06 | 1.65 | 2.28 | - |
Total Liabilities | 11.3 | 12.39 | 8.05 | 8.63 | 10.39 | 10.91 |
Common Stock | 0.04 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 537.25 | 537.2 | 528.82 | 515.93 | 508.58 | 501.89 |
Retained Earnings | -543.5 | -544.18 | -531.4 | -518.3 | -501.61 | -471.73 |
Shareholders' Equity | -6.21 | -6.93 | -2.56 | -2.37 | 6.98 | 30.17 |
Total Liabilities & Equity | 5.09 | 5.46 | 5.49 | 6.26 | 17.37 | 41.08 |
Total Debt | 4.26 | 2.98 | 3.38 | 2.85 | 3.83 | 4.11 |
Net Cash (Debt) | -2.92 | -1.23 | -1.61 | -0.26 | 9.48 | 33.07 |
Net Cash Growth | - | - | - | - | -71.35% | 188.44% |
Net Cash Per Share | -0.07 | -0.04 | -0.11 | -0.03 | 1.22 | 4.46 |
Filing Date Shares Outstanding | 43.5 | 43.5 | 29.76 | 12.34 | 8.33 | 7.48 |
Total Common Shares Outstanding | 43.5 | 43.48 | 17.41 | 10.65 | 8.31 | 7.48 |
Working Capital | -1.81 | 0.6 | -1.29 | 0.16 | 10.78 | 32.17 |
Book Value Per Share | -0.14 | -0.16 | -0.15 | -0.22 | 0.84 | 4.04 |
Tangible Book Value | -6.49 | -7.24 | -2.56 | -2.37 | 6.98 | 30.17 |
Tangible Book Value Per Share | -0.15 | -0.17 | -0.15 | -0.22 | 0.84 | 4.04 |
Machinery | - | 1.29 | 1.4 | 1.93 | 2.46 | 2.53 |
Leasehold Improvements | - | 0.07 | 0.07 | 0.05 | 0.72 | 0.72 |